ADIPOR1: Role in Hormone Regulation, Cellular Signaling, Inflammation and Cellular Processes

Target Name: ADIPOR1

NCBI ID: G51094

ADIPOR1

ADIPOR1: Role in Hormone Regulation, Cellular Signaling, Inflammation and Cellular Processes

ADIPOR1 (Progestin and adipoQ receptor family member 1) is a protein that is expressed in various tissues throughout the body, including the uterus, fat cells, and bone marrow. It is a member of the ADIPOR gene family, which is known for its role in the regulation of adipose tissue development and metabolism.

ADIPOR1 is a protein that is made up of 1,122 amino acids. It has a molecular weight of 114 kDa and a pre-fusion tag of 191 amino acids. ADIPOR1 is predominantly localized to the endoplasmic reticulum (ER), a system of organelles that transports and modifies proteins before they are released into the cytosol for further processing or degradation.

ADIPOR1 is a protein that is involved in the regulation of various cellular processes in the body, including metabolism, inflammation, and reproduction. One of its main functions is to regulate the levels of fat in the body, as it is a key receptor for progesterone, a hormone that is produced by the placenta to prepare the body for pregnancy.

In addition to its role in hormone regulation, ADIPOR1 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in several signaling pathways, including the TGF-β pathway, the Wnt pathway, and the FGF pathway.

ADIPOR1 has also been shown to be involved in the regulation of cellular processes that are related to inflammation. It has been shown to play a key role in the regulation of inflammation in the body, as it has been shown to interact with several different types of immune cells and to regulate the production of pro-inflammatory cytokines.

In addition to its role in inflammation, ADIPOR1 is also involved in the regulation of cellular processes that are related to cell survival. It has been shown to play a key role in the regulation of cell survival and to be involved in several processes that are related to cell death, such as apoptosis.

ADIPOR1 is also involved in the regulation of cellular processes that are related to the development and progression of cancer. It has been shown to play a key role in the regulation of cancer cell growth and to be involved in several processes that are related to cancer cell invasion and metastasis.

In conclusion, ADIPOR1 is a protein that is involved in a wide range of cellular processes that are important for the health and proper functioning of the body. As a member of the ADIPOR gene family, it is likely to be involved in the regulation of various physiological processes, including metabolism, inflammation, and reproduction. Additionally, ADIPOR1 may also be a drug target or biomarker for several diseases, including cancer, obesity, and inflammation. Further research is needed to fully understand the role of ADIPOR1 in the regulation of cellular processes and to develop effective treatments for these diseases.

Protein Name: Adiponectin Receptor 1

Functions: Receptor for ADIPOQ, an essential hormone secreted by adipocytes that regulates glucose and lipid metabolism (PubMed:25855295, PubMed:12802337). Required for normal glucose and fat homeostasis and for maintaining a normal body weight. ADIPOQ-binding activates a signaling cascade that leads to increased AMPK activity, and ultimately to increased fatty acid oxidation, increased glucose uptake and decreased gluconeogenesis. Has high affinity for globular adiponectin and low affinity for full-length adiponectin (By similarity)

The "ADIPOR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADIPOR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets